Over the last ten years, cell-based immunotherapy has emerged as a promising approach for treating solid tumors. Several companies, including Iovance Biotherapeutics, Obsidian Therapeutics,...
Nine-time Evo Champion and Guinness World Record Holder Brings Legendary Status to Captain New Team, Recruit Talent, and Advance Science's Role in Competitive Gaming...
WASHINGTON, Aug. 12, 2025 /PRNewswire/ -- The International Council of Beverages Associations (ICBA), the global voice for the non-alcoholic beverage industry, is pleased to...
Textile Waste Hit 120 Million Metric Tons in 2024 and Could Exceed 150 Million Metric Tons Annually Within the Next Five YearsNew BCG Report Explores...
Now Entering Its Third Decade, SIGGRAPH's Advances in Real-Time Rendering in Games Course has Become the Premier Forum for Unveiling Cutting-edge Rendering Techniques That...
BRANFORD, Conn., Aug. 11, 2025 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for...
Langenfeld, Germany, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Booking Health, a global leader in medical treatment coordination, today unveiled a new study titled Role of Immunotherapy in Extending Life Expectancy for Stage 4 Cervical Cancer Patients. The report outlines how cutting-edge immunotherapy is reshaping care for women with advanced cervical cancer, offering new pathways to longer survival and improved quality of life, particularly in cases resistant to standard treatments.
Student researchers from Mississippi State University and The Ohio State University received Boehringer Ingelheim research awards
DULUTH, Ga., Aug. 11, 2025 /PRNewswire/ -- Veterinary research took...
NEW YORK, Aug. 11, 2025 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the...
STAFFORD, Texas, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today provided the following update on CEO interviews and corporate events.
Brain Navi has officially landed in Spain!
TAIPEI, Aug.11, 2025 /PRNewswire/ -- Such an achievement has been made possible through the first of many collaborations...
The premier learning platform for India's Professional Audiovisual industry returns with a multi-track Summit focused on equipping professionals with critical insights into the technologies...
KUCHING, Malaysia, Aug. 11, 2025 /PRNewswire/ -- The Ministry of Energy and Environmental Sustainability Sarawak (MEESty) is pleased to announce the upcoming Public-Industry Engagement Day...